{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:00Z","timestamp":1787021220439,"version":"build-2736575974"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03188-3","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:51:02Z","timestamp":1753127462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Therapeutic Potential of Lipid Nanocarriers in Psoriasis Management: Advances and Applications"],"prefix":"10.1208","volume":"26","author":[{"given":"Atif","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-8325","authenticated-orcid":false,"given":"Poonam","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archita","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"3188_CR1","unstructured":"World Health Organization. Global report on psoriasis. World Health Organization, 2016."},{"issue":"10100","key":"3188_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","volume":"390","author":"SI Hay","year":"2017","unstructured":"Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, Aboyans V. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1260\u2013344.","journal-title":"The Lancet"},{"key":"3188_CR3","first-page":"1","volume":"20","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The Immunology of Psoriasis\u2014Current Concepts in Pathogenesis. Clin Rev Allergy Immunol. 2024;20:1\u201328.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"19","key":"3188_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"4\u20135","key":"3188_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4\u20135):490\u20135.","journal-title":"Autoimmun Rev"},{"key":"3188_CR6","first-page":"953","volume":"31","author":"G Micali","year":"2019","unstructured":"Micali G, Verz\u00ec AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol. 2019;31:953\u20139.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"3188_CR7","unstructured":"Shah M, Aboud DMA, Crane JS, Kumar S. Pustular psoriasis. Available\u00a0 from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537002\/#article-27963.s2. Accessed 20 Mar 2025"},{"issue":"6","key":"3188_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40265-020-01283-2","volume":"80","author":"S Shao","year":"2020","unstructured":"Shao S, Wang G, Maverakis E, Gudjonsson JE. Targeted treatment for erythrodermic psoriasis: rationale and recent advances. Drugs. 2020;80(6):525\u201334.","journal-title":"Drugs"},{"issue":"7","key":"3188_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00403-024-03036-7","volume":"316","author":"MA El-Basiony","year":"2024","unstructured":"El-Basiony MA, El-Komy MH, Samy NA, Aly DG, El-Gendy H, Hassan MF, El Sayed H, Soliman MM. Long-pulsed nd: YAG laser treatment of nail psoriasis: clinical and ultrasonographic assessment. Arch Dermatol Res. 2024;316(7):365.","journal-title":"Arch Dermatol Res"},{"issue":"10281","key":"3188_CR10","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CE Griffiths","year":"2021","unstructured":"Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. The Lancet. 2021;397(10281):1301\u201315.","journal-title":"The Lancet"},{"issue":"1","key":"3188_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.26452\/ijrps.v11i1.1831","volume":"11","author":"M Sharadha","year":"2020","unstructured":"Sharadha M, Gowda DV, Vishal Gupta N, Akhila AR. An overview on topical drug delivery system\u2013updated review. Int J Res Pharm Sci. 2020;11(1):368\u201385.","journal-title":"Int J Res Pharm Sci"},{"issue":"2","key":"3188_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/13543776.2016.1131267","volume":"26","author":"D Singh Malik","year":"2016","unstructured":"Singh Malik D, Mital N, Kaur G. Topical drug delivery systems: a patent review. Expert Opin Ther Pat. 2016;26(2):213\u201328.","journal-title":"Expert Opin Ther Pat"},{"key":"3188_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.18231\/j.ijced.2020.045","volume":"6","author":"YG Anupama","year":"2020","unstructured":"Anupama YG, Patil SB. A retrospective clinicohistopathological study of psoriasis. IP Indian J Clin Exp Dermatology. 2020;6:222\u20136.","journal-title":"IP Indian J Clin Exp Dermatology"},{"key":"3188_CR14","doi-asserted-by":"crossref","unstructured":"Kimmel GW, Lebwohl M. Psoriasis: overview and diagnosis. Evidence-Based Psoriasis: Diagnosis and Treatment. 2018;1\u20136.","DOI":"10.1007\/978-3-319-90107-7_1"},{"issue":"4","key":"3188_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","volume":"51","author":"RG Langley","year":"2004","unstructured":"Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment. J Am Acad Dermatol. 2004;51(4):563\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2004.04.012.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"3188_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/life11070627","volume":"11","author":"L Salgado-Boquete","year":"2021","unstructured":"Salgado-Boquete L, Carrascosa JM, Llamas-Velasco M, Ruiz-Villaverde R, De la Cueva P, Belinch\u00f3n I. A new classification of the severity of psoriasis: what\u2019s moderate psoriasis? Life. 2021;11(7):627.","journal-title":"Life"},{"issue":"4","key":"3188_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s13555-021-00544-6","volume":"11","author":"C Leonardi","year":"2021","unstructured":"Leonardi C, See K, Gallo G, McKean-Matthews M, Zhang Y, Goldblum O, Mallbris L, Burge R. Psoriasis severity assessment combining physician and patient reported outcomes: the optimal psoriasis assessment tool. Dermatol Ther. 2021;11(4):1249\u201363.","journal-title":"Dermatol Ther"},{"issue":"6","key":"3188_CR18","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s40744-023-00602-9","volume":"10","author":"N Frede","year":"2023","unstructured":"Frede N, Hiestand S, Schauer F, Endres D, Tebartz van Elst L, Zeisbrich M, Craig-Mueller N, Finzel S, Thiel J, Voll RE, Schempp C. Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms: a cross-sectional study of 300 patients. Rheumatol Ther. 2023;10(6):1655\u201368.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"3188_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/pharmaceutics17010056","volume":"17","author":"Y Gao","year":"2025","unstructured":"Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z, Yu H. Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research. Pharmaceutics. 2025;17(1):56.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3188_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jtumed.2021.02.008","volume":"16","author":"RS Bakar","year":"2021","unstructured":"Bakar RS, Jaapar SZ, Azmi AF, Aun YC. Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors. Journal of Taibah University Medical Sciences. 2021;16(4):491\u20136.","journal-title":"Journal of Taibah University Medical Sciences"},{"key":"3188_CR21","doi-asserted-by":"crossref","unstructured":"Hepat A, Chakole S, Rannaware A. Psychological well-being of adult psoriasis patients: a narrative review. Cureus. 2023;15(4).","DOI":"10.7759\/cureus.37702"},{"issue":"3","key":"3188_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.064.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"3188_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/PTT.S328572","volume":"10","author":"C Daugaard","year":"2022","unstructured":"Daugaard C, Iversen L, Hjuler KF. Comorbidity in Adult Psoriasis: Considerations for the Clinician. Psoriasis (Auckl). 2022;10(12):139\u201350. https:\/\/doi.org\/10.2147\/PTT.S328572.","journal-title":"Psoriasis (Auckl)"},{"issue":"13","key":"3188_CR24","doi-asserted-by":"publisher","first-page":"880201","DOI":"10.3389\/fimmu.2022.880201","volume":"10","author":"J Bu","year":"2022","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol. 2022;10(13):880201.","journal-title":"Front Immunol"},{"issue":"17","key":"3188_CR25","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Kim M. Challenges and Future Trends in the Treatment of Psoriasis. Int J Mol Sci. 2023;24(17):13313. https:\/\/doi.org\/10.3390\/ijms241713313.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3188_CR26","doi-asserted-by":"publisher","first-page":"e56890","DOI":"10.7759\/cureus.56890","volume":"16","author":"A Molla","year":"2024","unstructured":"Molla A. A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy. Cureus. 2024;16(3):e56890. https:\/\/doi.org\/10.7759\/cureus.56890.","journal-title":"Cureus"},{"key":"3188_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13671-018-0211-3","volume":"7","author":"ST Howell","year":"2018","unstructured":"Howell ST, Cardwell LA, Feldman SR. A Review and Update of Phototherapy Treatment Options for Psoriasis. Curr Derm Rep. 2018;7:43\u201351. https:\/\/doi.org\/10.1007\/s13671-018-0211-3.","journal-title":"Curr Derm Rep"},{"issue":"5","key":"3188_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4103\/idoj.IDOJ_113_21","volume":"12","author":"M Rajagopalan","year":"2021","unstructured":"Rajagopalan M, Chatterjee M, De A, Dogra S, Ganguly S, Kar BR, Madnani N, Neema S, Parasramani SG, Patel K, Tahiliani S. Systemic management of psoriasis patients in Indian scenario: an expert consensus. Indian Dermatol Online J. 2021;12(5):674\u201382.","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"3188_CR29","first-page":"189","volume":"17","author":"A Albaghdadi","year":"2017","unstructured":"Albaghdadi A. Current and under development treatment modalities of psoriasis: a review. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2017;17(3):189\u201399.","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"issue":"2","key":"3188_CR30","first-page":"319","volume":"1","author":"M Mikhail","year":"2004","unstructured":"Mikhail M, Scheinfeld NS. Therapy treatment options for psoriasis: topical and systemic. Clin Pract. 2004;1(2):319.","journal-title":"Clin Pract"},{"issue":"107","key":"3188_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","volume":"1","author":"M Pradhan","year":"2018","unstructured":"Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;1(107):447\u201363.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3188_CR32","doi-asserted-by":"publisher","first-page":"27910","DOI":"10.31083\/FBL27910","volume":"30","author":"T Kaur","year":"2025","unstructured":"Kaur T, Hinge N, Pukale S, Ansari MN, Thajudeen KY, Nandave M, Upadhyay J. Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management. Front Biosci-Landmark. 2025;30(3):27910.","journal-title":"Front Biosci-Landmark"},{"issue":"11","key":"3188_CR33","first-page":"1083","volume":"14","author":"SR Stefanov","year":"2021","unstructured":"Stefanov SR, Andonova VY. Lipid nanoparticulate drug delivery systems: recent advances in the treatment of skin disorders. Pharm. 2021;14(11):1083.","journal-title":"Pharm"},{"issue":"8","key":"3188_CR34","doi-asserted-by":"publisher","first-page":"783831","DOI":"10.3389\/fnut.2021.783831","volume":"1","author":"H Lu","year":"2021","unstructured":"Lu H, Zhang S, Wang J, Chen Q. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr. 2021;1(8):783831.","journal-title":"Front Nutr"},{"issue":"2","key":"3188_CR35","first-page":"656","volume":"15","author":"N Akombaetwa","year":"2023","unstructured":"Akombaetwa N, Ilangala AB, Thom L, Memvanga PB, Witika BA, Buya AB. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications. Pharm. 2023;15(2):656.","journal-title":"Pharm"},{"issue":"321","key":"3188_CR36","doi-asserted-by":"publisher","first-page":"103002","DOI":"10.1016\/j.cis.2023.103002","volume":"1","author":"F Motsoene","year":"2023","unstructured":"Motsoene F, Abrahamse H, Kumar SS. Multifunctional lipid-based nanoparticles for wound healing and antibacterial applications: A review. Adv Coll Interface Sci. 2023;1(321):103002.","journal-title":"Adv Coll Interface Sci"},{"key":"3188_CR37","doi-asserted-by":"crossref","unstructured":"Shukla T, Upmanyu N, Pandey SP, Gosh D. Lipid nanocarriers. In Lipid nanocarriers for drug targeting 2018 Jan 1 (pp. 1\u201347). William Andrew Publishing.","DOI":"10.1016\/B978-0-12-813687-4.00001-3"},{"issue":"2","key":"3188_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/cosmetics8020039","volume":"8","author":"D Khater","year":"2021","unstructured":"Khater D, Nsairat H, Odeh F, Saleh M, Jaber A, Alshaer W, Al Bawab A, Mubarak MS. Design, preparation, and characterization of effective dermal and transdermal lipid nanoparticles: a review. Cosmetics. 2021;8(2):39.","journal-title":"Cosmetics"},{"issue":"69","key":"3188_CR39","doi-asserted-by":"publisher","first-page":"103176","DOI":"10.1016\/j.jddst.2022.103176","volume":"1","author":"VG Jyothi","year":"2022","unstructured":"Jyothi VG, Ghouse SM, Khatri DK, Nanduri S, Singh SB, Madan J. Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration? J Drug Deliv Sci Technol. 2022;1(69):103176.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"16","key":"3188_CR40","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.2174\/0929867327666200831125656","volume":"28","author":"FG Baveloni","year":"2021","unstructured":"Baveloni FG, Riccio BV, Di Filippo LD, Fernandes MA, Meneguin AB, Chorilli M. Nanotechnology-based drug delivery systems as potential for skin application: a review. Curr Med Chem. 2021;28(16):3216\u201348.","journal-title":"Curr Med Chem"},{"issue":"3","key":"3188_CR41","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3390\/ijms24032978","volume":"24","author":"TS Patil","year":"2023","unstructured":"Patil TS, Gujarathi NA, Aher AA, Pachpande HE, Sharma C, Ojha S, Goyal SN, Agrawal YO. Recent advancements in topical anti-psoriatic nanostructured lipid carrier-based drug delivery. Int J Mol Sci. 2023;24(3):2978.","journal-title":"Int J Mol Sci"},{"issue":"46","key":"3188_CR42","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.1039\/d1ra06087b","volume":"11","author":"UU Mohd Nordin","year":"2021","unstructured":"Mohd Nordin UU, Ahmad N, Salim N, Mohd Yusof NS. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC Adv. 2021;11(46):29080\u2013101. https:\/\/doi.org\/10.1039\/d1ra06087b. (Erratum.In:RSCAdv.2022Aug2;12(33):21110.doi:10.1039\/d2ra90076a).","journal-title":"RSC Adv"},{"issue":"22","key":"3188_CR43","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","volume":"8","author":"N Raina","year":"2023","unstructured":"Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega. 2023;8(22):19145\u201367.","journal-title":"ACS Omega"},{"issue":"4","key":"3188_CR44","doi-asserted-by":"publisher","first-page":"1006628","DOI":"10.3389\/fnano.2022.1006628","volume":"21","author":"N Gupta","year":"2022","unstructured":"Gupta N, Gupta GD, Singh D. Localized topical drug delivery systems for skin cancer: Current approaches and future prospects. Front Nanotechnol. 2022;21(4):1006628.","journal-title":"Front Nanotechnol"},{"issue":"1","key":"3188_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cosmetics12010022","volume":"12","author":"D Santonocito","year":"2025","unstructured":"Santonocito D, Puglia C. Lipid Nanoparticles and Skin: Discoveries and Advances. Cosmetics. 2025;12(1):22.","journal-title":"Cosmetics"},{"issue":"147","key":"3188_CR46","doi-asserted-by":"publisher","first-page":"112633","DOI":"10.1016\/j.biopha.2022.112633","volume":"1","author":"C Hemrajani","year":"2022","unstructured":"Hemrajani C, Negi P, Parashar A, Gupta G, Jha NK, Singh SK, Chellappan DK, Dua K. Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed Pharmacother. 2022;1(147):112633.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"3188_CR47","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2174\/1389201024666221213144228","volume":"24","author":"S Bahadur","year":"2023","unstructured":"Bahadur S, Sharma M. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review. Curr Pharm Biotechnol. 2023;24(11):1383\u201396. https:\/\/doi.org\/10.2174\/1389201024666221213144228.","journal-title":"Curr Pharm Biotechnol"},{"issue":"355","key":"3188_CR48","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jconrel.2023.02.006","volume":"1","author":"AJ Guillot","year":"2023","unstructured":"Guillot AJ, Mart\u00ednez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. J Control Release. 2023;1(355):624\u201354.","journal-title":"J Control Release"},{"issue":"11","key":"3188_CR49","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2500 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"issue":"58","key":"3188_CR50","doi-asserted-by":"publisher","first-page":"101691","DOI":"10.1016\/j.jddst.2020.101691","volume":"1","author":"R Saka","year":"2020","unstructured":"Saka R, Jain H, Kommineni N, Chella N, Khan W. Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB\/c mice. J Drug Deliv Sci Technol. 2020;1(58):101691.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"68","key":"3188_CR51","doi-asserted-by":"publisher","first-page":"103103","DOI":"10.1016\/j.jddst.2022.103103","volume":"1","author":"H Jain","year":"2022","unstructured":"Jain H, Geetanjali D, Dalvi H, Bhat A, Godugu C, Srivastava S. Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis. J Drug Deliv Sci Technol. 2022;1(68):103103.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3188_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12951-020-00635-0","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, Shu Gf, Lu Kj, et al. Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis. J Nanobiotechnol. 2020;18:80. https:\/\/doi.org\/10.1186\/s12951-020-00635-0.","journal-title":"J Nanobiotechnol"},{"issue":"34","key":"3188_CR53","doi-asserted-by":"publisher","first-page":"40228","DOI":"10.1021\/acsami.3c07582","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gong S, Liu L, Shen H, Liu E, Pan L, Gao N, Chen R, Huang Y. Cyclodextrin-coordinated liposome-in-gel for transcutaneous quercetin delivery for psoriasis treatment. ACS Appl Mater Interfaces. 2023;15(34):40228\u201340.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"247","key":"3188_CR54","doi-asserted-by":"publisher","first-page":"114457","DOI":"10.1016\/j.colsurfb.2024.114457","volume":"1","author":"P Zhang","year":"2025","unstructured":"Zhang P, Tang J, Cheng L, Xue Y, Yang J, Sun Z, Liu J. Hyaluronic acid modified liposomes with enhanced transdermal delivery of methotrexate for psoriasis treatment. Colloids Surf, B. 2025;1(247):114457.","journal-title":"Colloids Surf, B"},{"issue":"5","key":"3188_CR55","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/1567201813666160520114436","volume":"14","author":"V Garg","year":"2017","unstructured":"Garg V, Singh H, Bimbrawh S, Kumar Singh S, Gulati M, Vaidya Y, Kaur P. Ethosomes and transfersomes: Principles, perspectives and practices. Curr Drug Deliv. 2017;14(5):613\u201333.","journal-title":"Curr Drug Deliv"},{"issue":"6","key":"3188_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","volume":"38","author":"AC Paiva-Santos","year":"2021","unstructured":"Paiva-Santos AC, Silva AL, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M, Mascarenhas-Melo F, Castro R, Veiga F. Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res. 2021;38(6):947\u201370.","journal-title":"Pharm Res"},{"issue":"1","key":"3188_CR57","first-page":"100027","volume":"1","author":"XQ Niu","year":"2019","unstructured":"Niu XQ, Zhang DP, Bian Q, Feng XF, Li H, Rao YF, Shen YM, Geng FN, Yuan AR, Ying XY, Gao JQ. Mechanism investigation of ethosomes transdermal permeation. Int J Pharm: X. 2019;1(1):100027.","journal-title":"Int J Pharm: X"},{"issue":"5","key":"3188_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/2211738507666190906123643","volume":"7","author":"A Chandra","year":"2019","unstructured":"Chandra A, Aggarwal G, Manchanda S, Narula A. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol. 2019;7(5):362\u201374.","journal-title":"Pharm Nanotechnol"},{"issue":"592","key":"3188_CR59","doi-asserted-by":"publisher","first-page":"119936","DOI":"10.1016\/j.ijpharm.2020.119936","volume":"5","author":"Y Li","year":"2021","unstructured":"Li Y, Xu F, Li X, Chen SY, Huang LY, Bian YY, Wang J, Shu YT, Yan GJ, Dong J, Yin SP. Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability. Int J Pharm. 2021;5(592):119936.","journal-title":"Int J Pharm"},{"key":"3188_CR60","doi-asserted-by":"publisher","first-page":"23866","DOI":"10.1038\/s41598-024-72951-6","volume":"14","author":"Y Mehmood","year":"2024","unstructured":"Mehmood Y, Shahid H, Ahmed S, et al. Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies. Sci Rep. 2024;14:23866. https:\/\/doi.org\/10.1038\/s41598-024-72951-6.","journal-title":"Sci Rep"},{"issue":"1","key":"3188_CR61","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12951-024-02860-3","volume":"22","author":"P Wang","year":"2024","unstructured":"Wang P, Hong S, Cao C, Guo S, Wang C, Chen X, Wang X, Song P, Li N, Xu R. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis. J Nanobiotechnol. 2024;22(1):584.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"3188_CR62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5530\/jyp.2024.16.53","volume":"16","author":"L Firdos","year":"2024","unstructured":"Firdos L, Haranath C, Yasaswini S, Sai RN, Satish T. Exploring Transferosomes: A Comprehensive Review of Novel Strategies and Applications in Drug Delivery. J Young Pharm. 2024;16(3):410\u20135.","journal-title":"J Young Pharm"},{"issue":"1","key":"3188_CR63","doi-asserted-by":"publisher","first-page":"e1918","DOI":"10.1002\/wnan.1918","volume":"16","author":"N Matharoo","year":"2024","unstructured":"Matharoo N, Mohd H, Michniak-Kohn B. Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments Wiley Interdisciplinary Reviews. Nanomed Nanobiotechnol. 2024;16(1):e1918.","journal-title":"Nanomed Nanobiotechnol"},{"key":"3188_CR64","doi-asserted-by":"crossref","unstructured":"Deshkar SS, Halyali AS, Thomas AB, Undale VR, Pagar RR, Nagore DH. Development and Optimization of Transferosomal Gel for Efficient Topical Delivery of Berberine Hydrochloride. Drug Deliv Lett. 2024.","DOI":"10.2174\/0122103031316213241026192712"},{"issue":"5","key":"3188_CR65","first-page":"660","volume":"13","author":"SS Dongare","year":"2024","unstructured":"Dongare SS, Bhogale VP. Development, optimization and evaluation of psoralen loaded transfersomal gel for treatment of psoriasis. 2024;13(5):660\u201387.","journal-title":"Development, optimization and evaluation of psoralen loaded transfersomal gel for treatment of psoriasis"},{"issue":"3","key":"3188_CR66","doi-asserted-by":"publisher","first-page":"553","DOI":"10.5599\/admet.2268","volume":"12","author":"S Singh","year":"2024","unstructured":"Singh S, Awasthi R. Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design. ADMET DMPK. 2024;12(3):553\u201380. https:\/\/doi.org\/10.5599\/admet.2268.","journal-title":"ADMET DMPK"},{"key":"3188_CR67","doi-asserted-by":"publisher","first-page":"118623","DOI":"10.1016\/j.ijpharm.2019.118623","volume":"569","author":"M Bahramizadeh","year":"2019","unstructured":"Bahramizadeh M, Bahramizadeh M, Kiafar B, Jafarian AH, Nikpoor AR, Hatamipour M, Esmaily H, Rezaeemehr Z, Golmohammadzadeh S, Moosavian SA, Jafari MR. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm. 2019;569:118623. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118623.","journal-title":"Int J Pharm"},{"issue":"6","key":"3188_CR68","first-page":"1593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharm. 2023;15(6):1593.","journal-title":"Pharm"},{"issue":"9","key":"3188_CR69","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/nano9091204","volume":"9","author":"A Essaghraoui","year":"2019","unstructured":"Essaghraoui A, Belfkira A, Hamdaoui B, Nunes C, Lima SA, Reis S. Improved dermal delivery of cyclosporine a loaded in solid lipid nanoparticles. Nanomater. 2019;9(9):1204.","journal-title":"Nanomater"},{"issue":"3","key":"3188_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"R Paliwal","year":"2020","unstructured":"Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: A review on recent perspectives and patents. Expert Opin Ther Pat. 2020;30(3):179\u201394.","journal-title":"Expert Opin Ther Pat"},{"key":"3188_CR71","doi-asserted-by":"crossref","unstructured":"Aland R, M G, Rao PR, D. V. R. N. B. Solid Lipid Nanoparticles for Topical Delivery of Acitretin for the Treatment of Psoriasis by Design of Experiment. Scopus Indexed [Internet]. 2020 Mar. 31 [cited 2025 Apr. 9];12(2):4474\u201391. Available from:https:\/\/www.ijpsnonline.com\/index.php\/ijpsn\/article\/view\/293. Accessed 9 Apr 2025","DOI":"10.37285\/ijpsn.2019.12.2.5"},{"issue":"63","key":"3188_CR72","doi-asserted-by":"publisher","first-page":"102442","DOI":"10.1016\/j.jddst.2021.102442","volume":"1","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Sharma S, Roy A, Alexander A, Singhvi G. Solid lipid nanocarriers embedded hydrogel for topical delivery of apremilast: In-vitro, ex-vivo, dermatopharmacokinetic and anti-psoriatic evaluation. J Drug Deliv Sci Technol. 2021;1(63):102442.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"168","key":"3188_CR73","doi-asserted-by":"publisher","first-page":"115823","DOI":"10.1016\/j.biopha.2023.115823","volume":"1","author":"P Rahmanian-Devin","year":"2023","unstructured":"Rahmanian-Devin P, Askari VR, Sanei-Far Z, Rahimi VB, Kamali H, Jaafari MR, Golmohammadzadeh S. Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions. Biomed Pharmacother. 2023;1(168):115823.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3188_CR74","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jsps.2023.04.007","volume":"31","author":"D Maiti","year":"2023","unstructured":"Maiti D, Inamdar MN, Almuqbil M, Suresh S, Asdaq SM, Alshehri S, Al Arfaj SA, Alamri AM, Aldohyan MM, Alqahtani MT, Alosaimi TM. Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity. Saudi Pharm J. 2023;31(6):834\u201344.","journal-title":"Saudi Pharm J"},{"issue":"2","key":"3188_CR75","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"I Chauhan","year":"2020","unstructured":"Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull. 2020;10(2):150.","journal-title":"Adv Pharm Bull"},{"issue":"36","key":"3188_CR76","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.2174\/1381612826666200614175236","volume":"26","author":"T Waghule","year":"2020","unstructured":"Waghule T, Rapalli VK, Gorantla S, Saha RN, Dubey SK, Puri A, Singhvi G. Nanostructured lipid carriers as potential drug delivery systems for skin disorders. Curr Pharm Des. 2020;26(36):4569\u201379.","journal-title":"Curr Pharm Des"},{"key":"3188_CR77","first-page":"100108","volume":"4","author":"P Goudanavar","year":"2025","unstructured":"Goudanavar P. Advancing topical drug delivery: NLC innovations in dermatological therepeutics. Nano Trends. 2025;4:100108.","journal-title":"Nano Trends"},{"issue":"56","key":"3188_CR78","doi-asserted-by":"publisher","first-page":"101568","DOI":"10.1016\/j.jddst.2020.101568","volume":"1","author":"A Sharma","year":"2020","unstructured":"Sharma A, Upadhyay DK, Sarma GS, Kaur N, Gupta GD, Narang RK, Rai VK. Squalene integrated NLC based gel of tamoxifen citrate for efficient treatment of psoriasis: A preclinical investigation. J Drug Deliv Sci Technol. 2020;1(56):101568.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"57","key":"3188_CR79","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.jddst.2020.101775","volume":"1","author":"A Qadir","year":"2020","unstructured":"Qadir A, Aqil M, Ali A, Warsi MH, Mujeeb M, Ahmad FJ, Ahmad S, Beg S. Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol. 2020;1(57):101775.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3188_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2174\/1874467213666200628135552","volume":"14","author":"A Dadwal","year":"2021","unstructured":"Dadwal A, Mishra N, Narang RK. Development and characterization of a clobetasol propionate nanostructured lipid carrier-based gel for the treatment of plaque psoriasis. Curr Mol Pharmacol. 2021;14(3):399\u2013411.","journal-title":"Curr Mol Pharmacol"},{"issue":"206","key":"3188_CR81","doi-asserted-by":"publisher","first-page":"111945","DOI":"10.1016\/j.colsurfb.2021.111945","volume":"1","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Sharma S, Roy A, Singhvi G. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. Colloids Surf, B. 2021;1(206):111945.","journal-title":"Colloids Surf, B"},{"issue":"3","key":"3188_CR82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1208\/s12249-024-02774-1","volume":"25","author":"P Biswasroy","year":"2024","unstructured":"Biswasroy P, Pradhan D, Pradhan DK, Ghosh G, Rath G. Development of Betulin-Loaded Nanostructured Lipid Carriers for the Management of Imiquimod-Induced Psoriasis. AAPS PharmSciTech. 2024;25(3):57.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3188_CR83","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/10837450.2024.2407854","volume":"29","author":"RM Khalil","year":"2024","unstructured":"Khalil RM, Abdelhameed MF, Abou Taleb S, El-Saied MA, Shalaby ES. Preparation and characterisation of esculetin-loaded nanostructured lipid carriers gels for topical treatment of UV-induced psoriasis. Pharm Dev Technol. 2024;29(8):886\u201398.","journal-title":"Pharm Dev Technol"},{"issue":"7","key":"3188_CR84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12249-024-02910-x","volume":"25","author":"F Momin","year":"2024","unstructured":"Momin F, Kevlani V, Rawal S, Patel R, Acharya S, Shah S. Antipsoriatic Effect of Silymarin NLCs Based Gel: In Vitro and In Vivo Activity. AAPS PharmSciTech. 2024;25(7):195.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"3188_CR85","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/pharmaceutics17040478","volume":"17","author":"A Rani","year":"2025","unstructured":"Rani A, Kaur R, Aldahish A, et al. Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis. Pharm. 2025;17(4):478. https:\/\/doi.org\/10.3390\/pharmaceutics17040478.","journal-title":"Pharm"},{"key":"3188_CR86","doi-asserted-by":"crossref","unstructured":"Stefanov SR, Andonova VY. Lipid Nanoparticulate Drug delivery Systems: Recent advances in the treatment of skin disorders. Pharmaceuticals [Internet]. 2021 Oct 26;14(11):1083. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8619682\/","DOI":"10.3390\/ph14111083"},{"issue":"3","key":"3188_CR87","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2022","unstructured":"Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2022;13(3):446.","journal-title":"Adv Pharm Bull"},{"issue":"7","key":"3188_CR88","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.7150\/thno.69999","volume":"12","author":"F Qu","year":"2022","unstructured":"Qu F, Geng R, Liu Y, Zhu J. Advanced nanocarrier-and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 2022;12(7):3372.","journal-title":"Theranostics"},{"issue":"147","key":"3188_CR89","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.colsurfb.2016.08.027","volume":"1","author":"M Shao","year":"2016","unstructured":"Shao M, Hussain Z, Thu HE, Khan S, Katas H, Ahmed TA, Tripathy M, Leng J, Qin HL, Bukhari SN. Drug nanocarrier, the future of atopic diseases: Advanced drug delivery systems and smart management of disease. Colloids Surf, B. 2016;1(147):475\u201391.","journal-title":"Colloids Surf, B"},{"issue":"1","key":"3188_CR90","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1515\/ntrev-2022-0109","volume":"11","author":"S Javed","year":"2022","unstructured":"Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnol Rev. 2022;11(1):1744\u201377.","journal-title":"Nanotechnol Rev"},{"issue":"4","key":"3188_CR91","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288\u2013303.","journal-title":"Res Pharm Sci"},{"issue":"2","key":"3188_CR92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ics.12452","volume":"40","author":"V Saez","year":"2018","unstructured":"Saez V, Souza ID, Mansur CR. Lipid nanoparticles (SLN & NLC) for delivery of vitamin E: A comprehensive review. Int J Cosmet Sci. 2018;40(2):103\u201316.","journal-title":"Int J Cosmet Sci"},{"key":"3188_CR93","doi-asserted-by":"crossref","unstructured":"Shukla T, Upmanyu N, Pandey SP, Gosh D. Lipid nanocarriers. InLipid nanocarriers for drug targeting 2018 Jan 1 (pp. 1\u201347). William Andrew Publishing.","DOI":"10.1016\/B978-0-12-813687-4.00001-3"},{"issue":"2","key":"3188_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000178866","volume":"22","author":"C Wiegand","year":"2009","unstructured":"Wiegand C, Hipler UC. Evaluation of biocompatibility and cytotoxicity using keratinocyte and fibroblast cultures. Skin Pharmacol Physiol. 2009;22(2):74\u201382.","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"3188_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/jfb5020043","volume":"5","author":"J L\u00f3pez-Garc\u00eda","year":"2014","unstructured":"L\u00f3pez-Garc\u00eda J, Lehock\u00fd M, Humpol\u00ed\u010dek P, S\u00e1ha P. HaCaT Keratinocytes Response on Antimicrobial Atelocollagen Substrates: Extent of Cytotoxicity, Cell Viability and Proliferation. J Funct Biomater. 2014;5(2):43\u201357. https:\/\/doi.org\/10.3390\/jfb5020043.","journal-title":"J Funct Biomater"},{"issue":"3","key":"3188_CR96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12249-024-02740-x","volume":"25","author":"WW van Osdol","year":"2024","unstructured":"van Osdol WW, Novakovic J, Le Merdy M, Tsakalozou E, Ghosh P, Spires J, Lukacova V. Predicting Human Dermal Drug Concentrations Using PBPK Modeling and Simulation: Clobetasol Propionate Case Study. AAPS PharmSciTech. 2024;25(3):39.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3188_CR97","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/srt.12037","volume":"19","author":"J du Plessis","year":"2013","unstructured":"du Plessis J, Stefaniak A, Eloff F, John S, Agner T, Chou TC, Nixon R, Steiner M, Franken A, Kudla I, Holness L. International guidelines for the in vivo assessment of skin properties in non-clinical settings: Part 2. transepidermal water loss and skin hydration. Skin Res Technol. 2013;19(3):265\u201378. https:\/\/doi.org\/10.1111\/srt.12037.","journal-title":"Skin Res Technol"},{"issue":"8","key":"3188_CR98","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/pharmaceutics12080729","volume":"12","author":"A Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs A, P\u00e9ter-H\u00e9deri D, Perei K, Budai-Sz\u0171cs M, L\u00e9ber A, G\u00e1csi A, Cs\u00e1nyi E, Berk\u00f3 S. Effects of Formulation Excipients on Skin Barrier Function in Creams Used in Pediatric Care. Pharm. 2020;12(8):729. https:\/\/doi.org\/10.3390\/pharmaceutics12080729.","journal-title":"Pharm"},{"key":"3188_CR99","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5487\/TR.2017.33.3.191","volume":"33","author":"M Lee","year":"2017","unstructured":"Lee M, Hwang JH, Lim KM. Alternatives to in vivo Draize rabbit eye and skin irritation tests with a focus on 3D reconstructed human cornea-like epithelium and epidermis models. Toxicol Res. 2017;33:191\u2013203.","journal-title":"Toxicol Res"},{"issue":"4","key":"3188_CR100","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tiv.2005.09.005","volume":"20","author":"O Doucet","year":"2006","unstructured":"Doucet O, Lanvin M, Thillou C, Linossier C, Pupat C, Merlin B, Zastrow L. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. Toxicol In Vitro. 2006;20(4):499\u2013512.","journal-title":"Toxicol In Vitro"},{"key":"3188_CR101","first-page":"100266","volume":"1","author":"AB Buya","year":"2024","unstructured":"Buya AB, Mahlangu P, Witika BA. From lab to industrial development of lipid nanocarriers using quality by design approach. Int J Pharm: X. 2024;1:100266.","journal-title":"Int J Pharm: X"},{"issue":"618","key":"3188_CR102","doi-asserted-by":"publisher","first-page":"121656","DOI":"10.1016\/j.ijpharm.2022.121656","volume":"25","author":"AC Paiva-Santos","year":"2022","unstructured":"Paiva-Santos AC, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. Int J Pharm. 2022;25(618):121656.","journal-title":"Int J Pharm"},{"issue":"36","key":"3188_CR103","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","volume":"28","author":"I Cs\u00f3ka","year":"2021","unstructured":"Cs\u00f3ka I, Ismail R, J\u00f3j\u00e1rt-Laczkovich O, Pallagi E. Regulatory considerations, challenges and risk-based approach in nanomedicine development. Curr Med Chem. 2021;28(36):7461\u201376.","journal-title":"Curr Med Chem"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03188-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:03:55Z","timestamp":1758729835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03188-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":103,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03188-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"The authors declare no financial or other conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"195"}}